{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-040182","form_type":"8-K/A","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2026-08-26T14:45:11+00:00","discovered_at":"2026-08-26T14:46:10.396042+00:00","generated_at":"2026-08-26T14:46:14.204458+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Interpace Biosciences stockholders approve 2026 equity incentive plan and ESPP","bullets":["Stockholders approved 2026 Equity Incentive Plan and 2026 ESPP at Aug 20, 2026 annual meeting.","New plans replace 2019 Equity Incentive Plan and 2019 ESPP; no further grants or purchases under old plans.","Material terms previously disclosed in proxy statement filed July 7, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-040182","json":"https://secwatch.observer/filing/0001493152-26-040182.json","markdown":"https://secwatch.observer/filing/0001493152-26-040182.md","text":"https://secwatch.observer/filing/0001493152-26-040182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226040182/0001493152-26-040182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226040182/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-26T14:46:14.204458+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}